Hansa Biopharma AB (HNSBF) Q3 2022 Earnings Call Transcript
seekingalpha.com
news
2022-10-20 15:35:05

Hansa Biopharma AB (OTCPK:HNSBF) Q3 2022 Earnings Conference Call October 20, 2022 8:00 AM ET Company Participants Soren Tulstrup - President and Chief Executive Officer Donato Spota - Senior Vice President, Chief Financial Officer Conference Call Participants Christopher Uhde - SEB Adam Karlsson - ABG Sundal Collier Douglas Tsao - H.C. Wainwright & Co Zoe Karamanoli - RBC Capital Markets Johan Unnerus - Redeye Dominic Rose - Intron Health Research Operator Hello, everyone, and welcome to the Hansa Biopharma Interim Report for January to September 2022.
